{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T13:23:04Z","timestamp":1782566584272,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019728","name":"Shizuoka Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019728","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K07180"],"award-info":[{"award-number":["20K07180"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K07158"],"award-info":[{"award-number":["20K07158"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K09917"],"award-info":[{"award-number":["24K09917"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmaceutical Science Advances"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.pscia.2025.100068","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T20:53:17Z","timestamp":1741639997000},"page":"100068","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Nasal powder formulation employing microenvironmental pH-modifier for rapid absorption of mirtazapine"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7781-1731","authenticated-orcid":false,"given":"Kohei","family":"Yamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsubasa","family":"Kihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Shinsato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7176-8354","authenticated-orcid":false,"given":"Hirofumi","family":"Yasui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihiro","family":"Shino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5155-2003","authenticated-orcid":false,"given":"Hideyuki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4527-1440","authenticated-orcid":false,"given":"Satomi","family":"Onoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.pscia.2025.100068_bib1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0028-3908(88)90149-9","article-title":"Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, Org 3770 and its enantiomers","volume":"27","author":"de Boer","year":"1988","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.pscia.2025.100068_bib2","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1017\/S1041610215002446","article-title":"Expert opinions on the first-line pharmacological treatment for delirium in Japan: a conjoint analysis","volume":"28","author":"Okumura","year":"2016","journal-title":"Int. Psychogeriatr."},{"issue":"11","key":"10.1016\/j.pscia.2025.100068_bib3","first-page":"1123","article-title":"Utility of mirtazapine for the treatment of delirium in geriatric patients","volume":"53","author":"Imanaka","year":"2011","journal-title":"Clinical psychiatry"},{"issue":"4","key":"10.1016\/j.pscia.2025.100068_bib4","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1533-2500.2005.00038.x","article-title":"Phantom limb pain treatment with mirtazapine: a case series","volume":"5","author":"Kuiken","year":"2005","journal-title":"Pain Pract."},{"issue":"S2","key":"10.1016\/j.pscia.2025.100068_bib5","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1002\/hup.470100803","article-title":"Bioavailability of mirtazapine from Remeron\u00ae tablets after single and multiple oral dosing","volume":"10","author":"Voortman","year":"1995","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"issue":"2","key":"10.1016\/j.pscia.2025.100068_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3999\/jscpt.50.23","article-title":"Clinical pharmacokinetics of mianserin suppositories in healthy older Japanese male adults: a pilot study","volume":"50","author":"Ichikura","year":"2019","journal-title":"Rinsho yakuri\/Japanese Journal of Clinical Pharmacology and Therapeutics"},{"issue":"1","key":"10.1016\/j.pscia.2025.100068_bib7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejpb.2014.03.004","article-title":"Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules","volume":"88","author":"Fortuna","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"7","key":"10.1016\/j.pscia.2025.100068_bib8","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1023\/A:1015830907632","article-title":"The nasal mucociliary clearance: relevance to nasal drug delivery","volume":"8","author":"Schipper","year":"1991","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.pscia.2025.100068_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0169-409X(97)00059-8","article-title":"Nasal mucociliary clearance as a factor in nasal drug delivery","volume":"29","author":"Marttin","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"10","key":"10.1016\/j.pscia.2025.100068_bib10","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1021\/acs.molpharmaceut.8b00464","article-title":"Quantitative estimation of the effect of nasal mucociliary function on in vivo absorption of norfloxacin after intranasal administration to rats","volume":"15","author":"Inoue","year":"2018","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.pscia.2025.100068_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2011.08.032","article-title":"Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications","volume":"420","author":"Kawabata","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.pscia.2025.100068_bib12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0169-409X(00)00130-7","article-title":"Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract1","volume":"46","author":"H\u00f6rter","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.pscia.2025.100068_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0378-5173(95)00033-F","article-title":"The effect of particle size and shape on the surface specific dissolution rate of microsized practically insoluble drugs","volume":"122","author":"Mosharraf","year":"1995","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/j.pscia.2025.100068_bib14","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1002\/jps.22009","article-title":"Impact of counterion on the chemical stability of crystalline salts of procaine","volume":"99","author":"Guerrieri","year":"2010","journal-title":"J. Pharmaceut. Sci."},{"issue":"4","key":"10.1016\/j.pscia.2025.100068_bib15","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1517\/17425247.2014.881798","article-title":"Microenvironmental pH-modification to improve dissolution behavior and oral absorption for drugs with pH-dependent solubility","volume":"11","author":"Taniguchi","year":"2014","journal-title":"Expet Opin. Drug Deliv."},{"issue":"2","key":"10.1016\/j.pscia.2025.100068_bib16","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3390\/pharmaceutics15020637","article-title":"Microenvironmental pH modification in buccal\/sublingual dosage forms for systemic drug delivery","volume":"15","author":"He","year":"2023","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.pscia.2025.100068_bib17","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/jps.20932","article-title":"Microenvironmental pH modulation in solid dosage forms","volume":"96","author":"Badawy","year":"2007","journal-title":"J. Pharmaceut. Sci."},{"issue":"8","key":"10.1016\/j.pscia.2025.100068_bib18","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/1520-6017(200008)89:8<1028::AID-JPS7>3.0.CO;2-3","article-title":"A novel apparatus for rat in vivo evaluation of dry powder formulations for pulmonary administration","volume":"89","author":"Okamoto","year":"2000","journal-title":"J. Pharmaceut. Sci."},{"issue":"5","key":"10.1016\/j.pscia.2025.100068_bib19","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/10837450.2024.2346292","article-title":"Nanocarriers with long-term retention in the respiratory system for prolonged drug exposure","volume":"29","author":"Yamada","year":"2024","journal-title":"Pharmaceut. Dev. Technol."},{"issue":"4","key":"10.1016\/j.pscia.2025.100068_bib20","first-page":"74","article-title":"Stress degradation studies and development of validated stability indicating method for assay of mirtazapine","volume":"1","author":"Bhusari","year":"2011","journal-title":"Res. J. Chem. Sci."},{"key":"10.1016\/j.pscia.2025.100068_bib21","first-page":"107","article-title":"Hydrotropic phenomena","volume":"76","author":"Neuberg","year":"1916","journal-title":"Biochem. Z."},{"key":"10.1016\/j.pscia.2025.100068_bib22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cocis.2016.03.005","article-title":"Hydrotropes","volume":"22","author":"Kunz","year":"2016","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"10.1016\/j.pscia.2025.100068_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121591","article-title":"Amino acid hydrotropes to increase the solubility of indomethacin and carbamazepine in aqueous solution","volume":"617","author":"Alsalhi","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.pscia.2025.100068_bib24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3390\/gels9060457","article-title":"Formulation of intranasal mucoadhesive thermotriggered in situ gel containing mirtazapine as an antidepressant drug","volume":"9","author":"Ghazwani","year":"2023","journal-title":"Gels"},{"issue":"8","key":"10.1016\/j.pscia.2025.100068_bib25","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1021\/ja01152a095","article-title":"Hygroscopicity of amino acids and its relationship to the vapor phase water absorption of Proteins2,3","volume":"73","author":"Mellon","year":"1951","journal-title":"J. Am. Chem. Soc."},{"issue":"4","key":"10.1016\/j.pscia.2025.100068_bib26","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2165\/00003495-199957040-00010","article-title":"Mirtazapine","volume":"57","author":"Holm","year":"1999","journal-title":"Drugs"}],"container-title":["Pharmaceutical Science Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2773216925000066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2773216925000066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T12:48:02Z","timestamp":1778935682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2773216925000066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":26,"alternative-id":["S2773216925000066"],"URL":"https:\/\/doi.org\/10.1016\/j.pscia.2025.100068","relation":{},"ISSN":["2773-2169"],"issn-type":[{"value":"2773-2169","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nasal powder formulation employing microenvironmental pH-modifier for rapid absorption of mirtazapine","name":"articletitle","label":"Article Title"},{"value":"Pharmaceutical Science Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pscia.2025.100068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Shandong University.","name":"copyright","label":"Copyright"}],"article-number":"100068"}}